CDKN2A and Miyoshi myopathy: Gene-specific promotor methylation is frequently observed in MM and can contribute to tumorigenesis by selectively and reversibly suppressing transcription of tumor suppressor genes, such as p16/INK4a (encoded by CDKN2A) [64].